Is INVO Fertility, Inc. (IVF) Halal?

NASDAQ Healthcare United States $19M
✗ NOT HALAL
Confidence: 90/100
INVO Fertility, Inc. (IVF) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 167.4% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. INVO Fertility, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 167.4%
/ 30%
12.5%
/ 30%
3.0%
/ 30%
6.87%
/ 5%
✗ NOT HALAL
DJIM 167.4%
/ 33%
12.5%
/ 33%
3.0%
/ 33%
6.87%
/ 5%
✗ NOT HALAL
MSCI 21.3%
/ 33%
1.6%
/ 33%
0.4%
/ 33%
6.87%
/ 5%
✗ NOT HALAL
S&P 167.4%
/ 33%
12.5%
/ 33%
3.0%
/ 33%
6.87%
/ 5%
✗ NOT HALAL
FTSE 21.3%
/ 33%
1.6%
/ 33%
0.4%
/ 50%
6.87%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1,474.40
P/B Ratio
-0.1
EV/EBITDA
-1.9
EV: $14M
Revenue
$7M
Growth: 22.6%
Current Ratio
0.1

Profitability

Gross Margin 39.2%
Operating Margin -93.1%
Net Margin 0.0%
Return on Assets (ROA) -48.4%

Cash Flow & Balance Sheet

Operating Cash Flow-$3M
Free Cash Flow-$3M
Total Debt$10M
Debt-to-Equity72.4
Current Ratio0.1
Total Assets$46M

Price & Trading

Last Close$2.88
50-Day MA$5.20
200-Day MA$36.59
Avg Volume7.4M
52-Week Range
$2.56
$384.00

About INVO Fertility, Inc. (IVF)

CEO
Mr. Steven M. Shum
Employees
33
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$19M
Currency
USD

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is INVO Fertility, Inc. (IVF) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), INVO Fertility, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is INVO Fertility, Inc.'s debt ratio?

INVO Fertility, Inc.'s debt ratio is 167.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.3%.

What are INVO Fertility, Inc.'s key financial metrics?

INVO Fertility, Inc. has a market capitalization of $19M, and revenue of $7M.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.